FDA Warns Companies Selling Fraudulent Cancer Treatments

Share this content:
FDA Warns Companies Selling Fraudulent Cancer Treatments
FDA Warns Companies Selling Fraudulent Cancer Treatments

WEDNESDAY, April 26, 2017 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) on Tuesday posted warning letters to 14 companies that are illegally selling more than 65 unproven cancer treatments.

The products include pills, capsules, powders, creams, teas, oils, and treatment and diagnostic kits. They're most commonly marketed and sold without FDA approval on websites and social media platforms, the FDA announcement of its action said. The treatments are frequently advertised as "natural" and often falsely labeled as dietary supplements, the agency added.

"Consumers should not use these or similar unproven products because they may be unsafe and could prevent a person from seeking an appropriate and potentially lifesaving cancer diagnosis or treatment," Douglas Stearn, director of the Office of Enforcement and Import Operations in the FDA's Office of Regulatory Affairs, said in a news release. "We encourage people to remain vigilant whether online or in a store and avoid purchasing products marketed to treat cancer without any proof they will work."

The FDA has issued more than 90 warning letters in the past 10 years to companies marketing hundreds of fraudulent products making cancer claims on websites, through social media, and in stores, the news release noted.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA Warns of Possible Heart Risks Linked to Clarithromycin

FDA Warns of Possible Heart Risks Linked to ...

Agency advising doctors to consider prescribing other antibiotics to patients with coronary heart disease

Artificial Intelligence May Help Prevent Physician Burnout

Artificial Intelligence May Help Prevent Physician Burnout

Many potential uses for AI, including improving searches and documentation, selecting treatment

Benzodiazepine Use Declining in Older Adults

Benzodiazepine Use Declining in Older Adults

Findings based on assessment of incidence, prevalence of use in three countries from 2010-2016

is free, fast, and customized just for you!

Already a member?

Sign In Now »